CD8A and kidney transplant: Altogether, our results provide mechanistic insight to the development of kidney transplant rejection in subjects receiving non-lymphodepletional induction therapy and suggest monitoring of circulating CD8+ DRTC over time may be a surrogate for ongoing allograft inflammation.